1. Home
  2. NVAX vs PAX Comparison

NVAX vs PAX Comparison

Compare NVAX & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • PAX
  • Stock Information
  • Founded
  • NVAX 1987
  • PAX 1988
  • Country
  • NVAX United States
  • PAX Cayman Islands
  • Employees
  • NVAX N/A
  • PAX N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • PAX Investment Managers
  • Sector
  • NVAX Health Care
  • PAX Finance
  • Exchange
  • NVAX Nasdaq
  • PAX Nasdaq
  • Market Cap
  • NVAX 1.3B
  • PAX 2.2B
  • IPO Year
  • NVAX 1995
  • PAX 2021
  • Fundamental
  • Price
  • NVAX $6.84
  • PAX $13.70
  • Analyst Decision
  • NVAX Buy
  • PAX Strong Buy
  • Analyst Count
  • NVAX 5
  • PAX 1
  • Target Price
  • NVAX $16.60
  • PAX $14.00
  • AVG Volume (30 Days)
  • NVAX 4.9M
  • PAX 503.7K
  • Earning Date
  • NVAX 08-07-2025
  • PAX 08-01-2025
  • Dividend Yield
  • NVAX N/A
  • PAX 6.40%
  • EPS Growth
  • NVAX N/A
  • PAX N/A
  • EPS
  • NVAX 2.97
  • PAX 0.45
  • Revenue
  • NVAX $1,254,962,000.00
  • PAX $389,900,000.00
  • Revenue This Year
  • NVAX $56.85
  • PAX $5.53
  • Revenue Next Year
  • NVAX N/A
  • PAX N/A
  • P/E Ratio
  • NVAX $2.30
  • PAX $30.16
  • Revenue Growth
  • NVAX 25.92
  • PAX 22.70
  • 52 Week Low
  • NVAX $5.01
  • PAX $9.43
  • 52 Week High
  • NVAX $17.81
  • PAX $14.52
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.12
  • PAX 50.56
  • Support Level
  • NVAX $6.54
  • PAX $13.60
  • Resistance Level
  • NVAX $7.20
  • PAX $14.52
  • Average True Range (ATR)
  • NVAX 0.28
  • PAX 0.26
  • MACD
  • NVAX 0.06
  • PAX -0.09
  • Stochastic Oscillator
  • NVAX 66.36
  • PAX 18.00

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

Share on Social Networks: